In November it became known that the Biontech / Pfizer vaccine showed 95 percent protection against Covid-19.

At the end of December, the vaccine was approved in the EU and Germany - as the first vaccine ever available here.

The federal government and the EU Commission, which primarily buys vaccination doses for the member states, took their time during these months.